The transplantation of bone marrow from another human is the only specific treatment available to personnel who have received radiation sufficient to cause death from the failure of the blood cell forming (hematopoietic) function of the bone marrow.
The transplanted donor cells will generally proliferate in such a host when the host's own marrow is unable to function; a portion of the donor cells, the immunocompetent cells, however, may recognize the host as foreign tissue and mount an immune attack. The outcome is usually fatal. The attack is known as the graft versus host reaction (GVHR); it is analogous to the more familiar host versus graft reaction in which host immunocompetent cells recognize and reject as foreign a transplanted organ. The GVHR may sometimes be reduced if the host and donor tissue types can be matched. Neither this laborious procedure nor other available treatments appear likely to eliminate by themselves the problem of GVHR. We therefore sought a way to provide tissue for transplantation with adequate hematopoietic stem cells but with reduced GVHR. Our studies were designed to test the hypothesis that a dose of pertussis (whooping cough) vaccine administered to donor animals would cause large numbers of immunocompetent lymphocytes to move out of the hematopoietic tissue and into the blood stream. This might reduce the number of GVHR cells in hematopoietic transplants but retain or increase the number of functional hematopoietic stem cells. Donor mice were treated with either a saline (control) solution or a pertussis vaccine preparation. Donor spleen cells, which in the mouse resemble human bone in marrow in their functions, were then transplanted by injection into recipient mice in experiments designed to test GVHR and hematopoietic stem cells quantitatively and specifically.
We observed that pertussis vaccination reduced the proportion of GVHR cells and increased the proportion of hematopoietic stem cells in donor mouse spleens. These two effects improved the treatment value of this hematopoietic transplant thirteenfold compared with control transplants. The findings suggest a general approach to GVHR which may have implications for the use of hematopoietic transplantation in cancer therapy, some anemias, and other conditions in addition to radiation injury. More animal experiments will be necessary to clarify the mechanism of the effects observed and to evaluate the clinical implications these results may have. or 20 million spleen cells from experimental or control donors were injected intraperitoneally into 6-to 10-day-old B6D2F^ mice. Three or four littermates were left uninjected. Litters of fewer than six animals were not used and animals over 10 in an individual litter were discarded. After the injection, the litter was returned to the mother for 9 days. The litter was then sacrificed and individual spleen and body weights were determined. The spleen index for each of the injected animals was calculated by dividing its spleen to body weight ratio by the average of the spleen to body weight ratios of the uninjected littermates.
Assays of hematopoietic stem cells. The hematopoietic stem cells of experimental or control donor spleen cell suspensions were determined by intravenous injections of 2.0 x 10° or 1.0 x 10 cells into lethally irradiated (850 rads) syngeneic recipients.
Irradiated control recipients received 0.4 ml HBSS. Untreated unirradiated control mice were also maintained and subjected to the hematopoietic assays. On the 10th day, 1 jiCi of Fe* was injected subcutaneously. Six hours later the mice were sacrificed and spleen and body weights determined. The radioactivity of a humerus and the spleen was determined in a scintillation counter. The spleens were fixed in Benin's solution and the number of macroscopic surface nodules on the spleen, each representing a hematopoietic colony forming unit (CFU), were counted.
In preliminary studies, the hematopoietic assays of C57BL/6J mice used as donors in the GVHR assay were compared with those of B6D2F2/J mice. Since spleen cells of pertussis vaccine pretreated or control donors from both strains produced similar hematopoietic responses in syngeneic recipients, all subsequent studies reported here were performed with B6D2F2/J donors in order to avoid the high early postirradiation mortality of C57BL/6 mice.
* As ferrous citrate at pH 6.8. New England Nuclear Corporation, Boston, Massachusetts Cytological studies. In separate experiments, animals of each of the donor strains were injected with either unheated pertussis vaccine, heated pertussis vaccine or saline as described above. At 3 days, total and differential leukocyte counts were determined, body and spleen weights were measured, and a touch preparation of the spleen was stained with Wright-Leishman's stain. Total nucleated cells per spleen were calculated from counts of aliquots of pooled spleen suspensions diluted in 3 percent acetic acid.
Statistical analyses. The t-test was used to compare averages of values obtained. Differences are reported as significant when p<0.05.
III. RESULTS
Effects of the vaccine preparations used on donor mice are shown in Figure 1 . As a control experiment for the assay of the GVHR, separate assays reported in Table I were performed in B6D2F-L neonates but, instead of the parental strain, donors were syngeneic B6D2F 1 /j adults receiving pretreatment identical to that of the C57BL/6J parental strain donors. The observed absence of significant changes in the average spleen indices of neonatal B6D2F 1 recipients after injection with syngeneic cells from control or experimental donors is consistent with the interpretation that the splenomegaly induced in the spleen assay of the GVHR required a histocompatibility difference between donor and recipient, and excludes the possibility that the GVHR assay shown in Figure 2 was influenced by factitious splenomegaly such as might be caused by vaccine carried with the donor cells. 1.00 + 0.07* 5 5 1.14+ 0.08 10 5 1.00 + 0.09
Heated pertussis vaccine 5 5 0.99 + 0-10 10 6 0.99 + 0.02 20 6 1.08+0.05 t Unheated pertussis vaccine 5 5 0.97 + 0.07 10 6 0.97+ 0.08 20 6 1.12+ 0.08 day for (A) spleen colonies, (B) spleen 59p e uptake, (C) spleen weight, (D) humerus 59p e uptake, and (E) body weight.
vaccine produced the largest average indices, followed by inocula from donors pretreated with unheated vaccine. Control cell inocula produced the smallest indices.
Inocula from donors pretreated with heated vaccine resulted in increased average body weights in the recipients but inocula from donors pretreated with unheated vaccine resulted in average body weights about the same as those resulting from control cell inocula.
Since the number of CFU counted is linearly related to the number of hemato- 
IV. DISCUSSION
The present studies showed that following pertussis vaccination, the GVHR of donor mouse spleen cells was reduced to 17 percent of control reactivity when the cells were transplanted across an H-2 histocompatibility difference. Pertussis vaccination was also shown to lead to more than twice the number of hematopoietic stem cells in donor spleens when assayed as splenic CFU in irradiated syngeneic recipients. Each of these findings will be discussed separately, followed by a discussion of their implications when considered together.
Reduction in GVHR. Other evidence had suggested that the increase in blood lymphocyte counts following pertussis vaccination results through mobilization of thymus-dependent lymphocytes, 21 ' 38 the cell population thought to cause the 14 17 37 GVHR. ' ' The vaccine used in the present studies increased donor blood lymphocyte counts, and also reduced the proportion of GVHR cells in donor spleens.
When the vaccine was heated to remove its capacity to mobilize lymphocytes, however, it was still effective in reducing the GVHR to 38 percent of control reactivity.
Therefore, not all of the effect of the pertussis vaccine on the GVHR is likely to be due to the mobilization of lymphocytes.
If mobilization of the GVHR cells into the peripheral blood is important in the effect of the unheated vaccine in reducing the GVHR of the donor spleen, one would predict that the net GVHR of the peripheral blood would be increased. Prior comparisons of the proportion of GVHR cells of peripheral blood from pertussis vaccine pretreated and control donors showed decreased reactivity in the mouse^ but increased 24 reactivity in the rat.
To quantitate the total blood GVHR relative to control or other organ reactivity, however, it would be necessary to know the volume of distribution of the reactive cells in the donor and to use a GVHR assay demonstrated to produce effects dependent upon the number of reactive cells injected. In neither of the studies of peripheral blood were these requirements met. Thus, it remains to be answered whether there is an increase in the total number of GVHR cells in the peripheral blood after pertussis vaccination.
Since we have no direct proof that unheated vaccine shifts GVHR cells into the blood, and since the heated vaccine reduced spleen GVHR without apparently mobilizing cells, mechanisms other than lymphocyte mobilization should be considered to account at least partially for the ability of the vaccine to reduce the GVHR. A simple alternative mechanism would be the dilution in the donor spleen of GVHR cells by unreactive cells. This would lead to a reduction in the proportion of GVHR cells.
Unheated vaccine led to a 2.1-fold increase in the number of spleen cells, which could account for a reduction to as little as 48 percent of control reactivity; heated vaccine led to a 1. 6-fold increase in the number of spleen cells, which could account for a reduction to about 63 percent of control reactivity. Thus, dilution alone could account for a major portion of the observed reduction in GVHR if a large portion of the additional cells in the spleens were inactive in the assay.
A third possible mechanism for the observed reduction in the GVHR is reduced entry of the parental spleen GVHR cells into the spleens of the Fj neonatal recipients.
Recipient splenomegaly and thus apparent GVHR would thereby be diminished. This may be unlikely if the behavior of our spleen cells is comparable to that reported by The finding that donor spleen hematopoietic stem cells are increased after pretreatment with either heated or unheated vaccine adds support to the interpretation that endotoxin, which is heat stable, may be responsible for the increase in hematopoiesis which pertussis vaccine may produce.
Other bacterial endotoxin preparations ' as well as a variety of other antigens, ' stimulate erythropoiesis.
Studies using purified B. pertussis endotoxin might clarify this possible relationship.
1C
The observation that recipient bone marrow iron uptake remained depressed to the level of the irradiated controls regardless of the treatment or dose employed is in accord with findings by others that marrow erythropoiesis is not an important component of the erythropoietic recovery of these irradiated mice 10 days after radiation and transplantation of hematopoietic tissue. spleen cell fractionation on a discontinuous albumin gradient produced a fraction with more than a tenfold increase in hematopoietic cells and less than 10 percent of the GVHR compared to the control suspension. The resulting CFU to GVHR ratio of greater than 100 for the 3-5 percent of cells recovered may be compared with the CFU to GVHR ratio of 13 found in the present study.
The more general use by other investigators of parallel quantitative assays of the GVHR and hematopoiesis would aid in further comparisons of treatments and would facilitate the evaluation of two or more treatment methods applied to the same hematopoietic transplant.
Further studies seem warranted to determine whether pertussis vaccine, its modified fractions, or other agents which duplicate useful properties of the vaccine, may have eventual therapeutic implications in human marrow transplantation. The graft versus host reactivity (GVHR) and hematopoietic stem cells of spleen cell inocula were assayed 3 days after pretreatment of donor mice with heated or unheated pertussis vaccine. Unheated vaccine reduced GVHR to 17 percent of control reactivity, measured by the Simonsen spleen weight assay, and increased 2, 2-fold the proportion of hematopoietic stem cells, assayed as colony forming units (CFU). Heated vaccine, which did not produce the lymphocytosis induced in donors by unheated vaccine, reduced GVHR to 38 percent of control reactivity, and increased the proportion of CFU 3, 8-fold. Alternative mechanisms for these effects are discussed.
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